Wiley and AlphaMed Press announce expanded co-publishing partnership
09-Sep-16, Wiley
John Wiley and Sons and The AlphaMed Company have announced an expanded co-publishing partnership for AlphaMed’s portfolio of scholarly journals in stem cell research, regenerative and translational medicine, and oncology.
%20Wiley.jpg "Wiley and AlphaMed Press Announce Expanded Co publishing Partnership (c) Wiley")
Image: Wiley
Beginning in January 2017, Wiley will assume co-publishing responsibility for AlphaMed’s publication, The Oncologist, along with its Open Access journal, STEM CELLS Translational Medicine. Wiley will continue to co-publish STEM CELLS.
This expanded partnership will enhance AlphaMed’s reach and visibility, providing authors and readers with digital and technological capabilities by Wiley.